XERIS PHARMACEUTICALS INC — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c5cf313c-17d2-4f54-8709-69da910ca595/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $20.2M | 2020-01-01 – 2020-12-31 | evidence 0001346302-21-000026 |
| FY 2019 | $1.6M | 2019-01-01 – 2019-12-31 | evidence 0001346302-20-000007 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001346302-20-000007 |
| FY 2017 | $16.0k | 2017-01-01 – 2017-12-31 | evidence 0001346302-19-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
XERIS PHARMACEUTICALS INC — all facts · Net Income · Operating Income